OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+39.37%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$191M
AUM Growth
+$191M
(+28%)
Cap. Flow
-$2.19M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
52.91%
Holding
54
New
5
Increased
14
Reduced
20
Closed
10
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$15.9M |
| 2 |
Prothena Corp
PRTA
|
$3M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$2.88M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$2.38M |
| 5 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$1.4M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$3.38M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$2.81M |
| 3 |
Indaptus Therapeutics
INDP
|
$2.79M |
| 4 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$2.58M |
| 5 |
Supernus Pharmaceuticals
SUPN
|
$2.55M |
Sector Composition
| 1 | Healthcare | 86.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
1
DELISTED
Blueprint Medicines
BPMC
| $23.3M | 12.2% | 785,000 +535,000 | +214% | +$15.9M |
|
2
Axogen
AXGN
$743M
| $18.1M | 9.45% | 2,000,000 -120,000 | -6% | -$1.08M |
|
|
ARIA
3
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $14.3M | 7.49% | 1,045,000 -205,000 | -16% | -$2.81M |
|
|
GNMX
4
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $10M | 5.25% | 1,800,000 -150,000 | -8% | -$836K |
|
|
5
Agios Pharmaceuticals
AGIO
$2.19B
| $6.87M | 3.59% | 130,000 +45,000 | +53% | +$2.38M |
|
6
FibroGen
FGEN
$47.8M
| $6.83M | 3.57% | 330,000 | – | – |
|
|
FOMX
7
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $5.83M | 3.05% | 630,000 -65,000 | -9% | -$602K |
|
|
TVRD
8
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $5.64M | 2.95% | 675,000 -160,000 | -19% | -$1.34M |
|
9
Codexis
CDXS
$246M
| $5.2M | 2.72% | 1,170,000 -8,500 | -0.7% | -$37.7K |
|
|
CYNA
10
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $5.03M | 2.63% | 125,000 | – | – |
|
|
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.99M | 2.61% | 275,000 +75,000 | +38% | +$1.36M |
|
|
EGRX
12
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.9M | 2.56% | 70,000 +20,000 | +40% | +$1.4M |
|
13
Harrow
HROW
$1.44B
| $4.63M | 2.42% | 1,215,381 -52,119 | -4% | -$199K |
|
|
GBT
14
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.61M | 2.41% | 200,000 +48,000 | +32% | +$1.11M |
|
15
MacroGenics
MGNX
$112M
| $4.34M | 2.27% | 145,000 +33,000 | +29% | +$987K |
|
|
CMRX
16
DELISTED
Chimerix, Inc.
CMRX
| $4.32M | 2.26% | 780,000 +105,000 | +16% | +$582K |
|
17
Neurogene
NGNE
$264M
| $4.14M | 2.17% | 310,000 +15,000 | +5% | +$200K |
|
|
ADMS
18
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $4.1M | 2.15% | 250,000 -50,000 | -17% | -$821K |
|
|
IMMU
19
DELISTED
Immunomedics Inc
IMMU
| $3.9M | 2.04% | 1,200,000 -100,000 | -8% | -$325K |
|
20
Xenon Pharmaceuticals
XENE
$2.98B
| $3.32M | 1.74% | 410,000 | – | – |
|
|
21
Prothena Corp
PRTA
$441M
| $3M | 1.57% | +50,000 | New | +$3M |
|
22
PDS Biotechnology
PDSB
$57.8M
| $2.92M | 1.53% | 280,000 +54,400 | +24% | +$566K |
|
|
LOXO
23
DELISTED
Loxo Oncology, Inc
LOXO
| $2.88M | 1.51% | +110,000 | New | +$2.88M |
|
|
TRIL
24
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.59M | 1.35% | 175,000 -20,000 | -10% | -$296K |
|
|
ZGNX
25
DELISTED
Zogenix, Inc.
ZGNX
| $2.52M | 1.32% | 220,000 -20,000 | -8% | -$229K |
|